With glucagon-like peptide 1 (GLP-1) agonists now close to inducing weight loss at levels only seen before through surgical intervention, obesity specialists say patients on these drugs are ...
CHICAGO — Combined use of semaglutide with an investigational monoclonal antibody called bimagrumab produced significant fat mass loss while preserving lean mass, results from the phase 2b BELIEVE ...
As you age, you gradually lose muscle mass and gain visceral body fat, a type of fat deep inside your body that surrounds your heart, kidneys and other organs. Now, scientists say the ratio of ...
In the battle of the obesity bulge, glucagon-like peptide-1 receptor agonist medications — aka GLP-1s such as Wegovy and Zepbound — have changed the game for some people who've struggled to ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Some patient populations may be at higher risk for lean ...
GLP-1 agonist medications (Ozempic and Wegovy) and dual GIP/GLP-1 receptor agonist medications (Zepbound and Mounjoaro) are powerful tools for weight loss, but losing weight rapidly can also lead the ...
Share on Pinterest Scientists have found a protein that may aid GLP-1 users in maintaining their muscle mass. Bloomberg/Getty Images One big area of concern for users of GLP-1 medications such as ...
3 Grupo Mixto de Fragilidad y Envejecimiento Exitoso UCLM-SESCAM, Universidad de Castilla-La Mancha-Servicio de Salud de Castilla-La Mancha, IDISCAM, Toledo, Spain This PhD thesis aimed: (i) to assess ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results